Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's Lillian Yin

This article was originally published in The Gray Sheet

Executive Summary

Director of the division of reproductive, abdominal, ear nose & throat and radiological devices in FDA's Office of Device Evaluation moves to the Center for Biologics Evaluation and Research in order to work on CBER's action plan for the regulation of devices ("The Gray Sheet" Dec. 7, p. 22). DRAERD Chief Medical Officer Dan Schultz is replacing Yin on an acting basis. Also leaving CDRH to join CBER is Mary Beth Jacobs, director of the division of life sciences within the Office of Science and Technology
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT011092

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel